A woman gives birth after receivng a uterine transplant for the first time in the US; a once-monthly treatment for patients with poioid addiction gains FDA approval; and LA public health officials launch an initiative to reduce the annual number HIV infections.
For the first time in the United States, a woman has delivered a baby following a uterine transplant, reported The New York Times. The mother, who was born without a uterus, received the transplant last year from a living donor at the Baylor University Medical Center in Dallas. The transplants are temporary, allowing a woman to have 1 or 2 children, and then are removed. Until now, all other births following uterine transplant occurred in Sweden, at the Sahlgrenska University Hospital in Gothenburg.The first monthly treatment for addiction to opiates, Indivior Plc’s Sublocade, has been approved by the FDA, according to Bloomberg. The treatment is an injection of buprenorphine, a drug that weakens withdrawal symptoms in patients with addiction. Its infrequent dosing could help patients better adhere to the regimen compared with current treatments, said the FDA. The treatment will be available early next year, according to Indivior.With more than 600,000 people living with HIV in the county, Los Angeles public health officials have launched an effort to reduce the annual number of HIV infections, according to The Los Angeles Times. The officials have set their focus on reducing the annual HIV infections, increasing the proportion of people with HIV who are diagnosed, and increasing the proportion of the population who are virally suppressed. They plan to accomplish these goals through encouraging community health centers and private medical providers to focus on preventive care.